中医临床研究
中醫臨床研究
중의림상연구
CLINICAL JOURNAL OF CHINESE MEDICINE
2014年
36期
79-81
,共3页
苑磊%成月英%张红%王卫勇%田苗%黄春丽%郭兴%周敏杰%郭彦聪
苑磊%成月英%張紅%王衛勇%田苗%黃春麗%郭興%週敏傑%郭彥聰
원뢰%성월영%장홍%왕위용%전묘%황춘려%곽흥%주민걸%곽언총
急性肾功能衰竭%川芎嗪%黄芪%甘露醇
急性腎功能衰竭%川芎嗪%黃芪%甘露醇
급성신공능쇠갈%천궁진%황기%감로순
Acute renal failure%Tetromethylpyrazine%Astragalus membranaceus%Mannitol
目的:观察川芎嗪注射液联合黄芪注射液在治疗甘露醇导致急性肾功能衰竭的作用。方法:甘露醇导致急性肾功能衰竭患者70例,其中38例为治疗组,32例为对照组。治疗组均给予常规治疗,包括原发病治疗、立即停用甘露醇给予利尿、控制血压,纠正水、电解质酸碱平衡紊乱,在上述治疗的基础上给予川芎嗪注射液联合黄芪注射液;对照组单纯给予常规治疗。观察治疗组和对照组疗效及两组治疗前后血生化的变化。结果:治疗组总有效率86.8%,对照组总有效率71.8%,两组差异有显著性;治疗组治疗前后各生化指标变化差异有显著性,对照组治疗前后各生化指标变化差异无显著性。结论:川芎嗪联合黄芪注射液治疗甘露醇导致急性肾功能衰竭的临床疗效显著。
目的:觀察川芎嗪註射液聯閤黃芪註射液在治療甘露醇導緻急性腎功能衰竭的作用。方法:甘露醇導緻急性腎功能衰竭患者70例,其中38例為治療組,32例為對照組。治療組均給予常規治療,包括原髮病治療、立即停用甘露醇給予利尿、控製血壓,糾正水、電解質痠堿平衡紊亂,在上述治療的基礎上給予川芎嗪註射液聯閤黃芪註射液;對照組單純給予常規治療。觀察治療組和對照組療效及兩組治療前後血生化的變化。結果:治療組總有效率86.8%,對照組總有效率71.8%,兩組差異有顯著性;治療組治療前後各生化指標變化差異有顯著性,對照組治療前後各生化指標變化差異無顯著性。結論:川芎嗪聯閤黃芪註射液治療甘露醇導緻急性腎功能衰竭的臨床療效顯著。
목적:관찰천궁진주사액연합황기주사액재치료감로순도치급성신공능쇠갈적작용。방법:감로순도치급성신공능쇠갈환자70례,기중38례위치료조,32례위대조조。치료조균급여상규치료,포괄원발병치료、립즉정용감로순급여이뇨、공제혈압,규정수、전해질산감평형문란,재상술치료적기출상급여천궁진주사액연합황기주사액;대조조단순급여상규치료。관찰치료조화대조조료효급량조치료전후혈생화적변화。결과:치료조총유효솔86.8%,대조조총유효솔71.8%,량조차이유현저성;치료조치료전후각생화지표변화차이유현저성,대조조치료전후각생화지표변화차이무현저성。결론:천궁진연합황기주사액치료감로순도치급성신공능쇠갈적림상료효현저。
Objective: To observe the effects of tetromethylpyrazine injections combined with astragalu injections on mannitol-induced acute renal failure. Methods:70 mannitol-induced renal failure patients were divided into treatment group (of 38 cases) and control group (of 32 cases). The treatment group was given the conventional treatment (which included primary disease treatment, immediate termination of mannitol medication and switch to alternative diuresis methods, blood pressure control and the treatment of water, electrolyte and acid/base balance disorders) combined with ligustrazine and astragalus injections. The control group received only the conventional treatment. Theraputic effectiveness and changes in blood biochemistry were monitored and measured before and after treatment to ensure treatment effects. Results:There was a significant difference between the control group and the treatment group. The therapeutic effectiveness of the treatment group was 86.6% while the therapeutic effectiveness of the control group was 71.8%. The treatment group showed significant indications of blood biochemical changes before and after treatment, whereas the control group showed no significant differences before and after treatment measures. Conclusion: The combination of Astragalu and tetromethylpyrazine injections proves significant effects on mannitol-induced acute renal failure.